Skip to main content
Caplight Logo









Cellevate AB

Cellevate AB

Private
LundHealthcare & Life Scienceshttps://cellevate.com/

Last Round

VC Round

Feb 1, 2026

Total Funding Raised

$6.97M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellevate AB is a biotechnology company that offers next-generation cell culture products for upstream bioprocessing, powered by its proprietary nanofiber technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Advanced Materials, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

nanofiber microcarriers3D cell cultureupstream bioprocessingviral vector productioncell and gene therapyCGT manufacturingbiopharmaceutical manufacturingbioprocess intensificationvaccine productionnanofiber scaffoldbioreactor consumablesAAV productionCDMO toolsiPSCsinduced pluripotent stem cellscellulose microcarriers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellevate AB Comparables

Compare Cellevate AB with similar companies based on industry and business-model similarity.

Cellevate AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Smart MCs
78%
Thermo Fisher Scientific Inc.
77%
3D Biotek
77%

Cellevate AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 1, 2026
GrantApr 25, 2025
SeedSep 16, 2024
SeedOct 10, 2023

Key People

Founding team and executive leadership

Laura Chirica

Chief Executive Officer

Executive Team

Christel Fenge

Chief Technology Officer

Executive Team

Linda Dexlin Mellby

Chief Operating Officer, Vice President Research And Development

Executive Team

Cellevate AB Investors

Notable investors and investment history

Cellevate AB investors
InvestorRounds
European Innovation Council FundSeed
Eurostars SME programmeGrant
Onsight VenturesSeed
Almi Invest ABVC Round
IndustrifondenVC Round, Seed
EIC FundVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 17, 2026

    Monthly visitors increased 51% MoM to 1.2K.

  • Feb 1, 2026

    $1.94M round with Almi Invest, Industrifonden, and EIC Fund.

Cellevate AB Filings

Explore SEC and related filing metadata, where available.

Cellevate AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellevate AB's valuation, stock price, and market status.

Is Cellevate AB a public or private company?

Cellevate AB is a private company.

What is the current stock price of Cellevate AB?

Cellevate AB is a private company with no public stock price. No recent secondary market data is available.

How much is Cellevate AB worth (valuation)?

Valuation information for Cellevate AB is not publicly available.

Can I buy Cellevate AB stock?

Cellevate AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellevate AB's last funding round?

Cellevate AB's most recent funding round was VC Round on February 1, 2026.

Who are the main investors in Cellevate AB?

Key investors in Cellevate AB include Industrifonden.

Will Cellevate AB IPO soon?

No public IPO plans have been announced for Cellevate AB.

How can I track Cellevate AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellevate AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLund
Employee Range14
Year Founded2014
Last FundingFeb 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?